{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:52:02Z","timestamp":1794732722583,"version":"4.9.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Lupus Victoria"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arthritis Australia and the Australian Rheumatology Association"},{"name":"NHMRC-Australian Research Council Dementia Research Development Fellowship"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Astra Zeneca"},{"name":"BristolMyersSquibb"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cognitive dysfunction, and comorbidities such as mood disorder and fibromyalgia, are common in SLE. This study aims to explore the associations between fibromyalgia, mood disorders, cognitive symptoms and cognitive dysfunction in SLE patients, and their impact on quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We tested cognition in SLE patients and healthy controls, and evaluated cognitive symptoms, mood disorder, fibromyalgia, fatigue and quality of life using patient-reported outcome measures. We examined associations of these comorbidities with both patient-reported cognitive symptoms and cognitive test performance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>High fibromyalgia symptom score and history of depression or anxiety were associated with cognitive dysfunction. There were no significant associations between current depression, anxiety symptoms or fatigue score and objective cognitive dysfunction. In contrast, mood disorder symptoms, history of mood disorder, fibromyalgia symptoms and fatigue all had significant associations with patient-reported cognitive symptoms. There were no significant associations between patient-reported cognitive symptoms and objective cognitive dysfunction. Objective cognitive dysfunction, patient-reported cognitive symptoms, history of mood disorder and fibromyalgia symptoms all had significant associations with poorer quality of life; fibromyalgia had the biggest impact.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Cognitive symptoms are common in SLE, but there were no associations between cognitive symptoms and objective cognitive dysfunction. Depression, anxiety and fibromyalgia were more consistently associated with patient-reported cognitive symptoms than with objective cognitive dysfunction. These factors all have a significant impact on quality of life. Understanding the discrepancy between patient-reported cognitive symptoms and cognitive test performance is essential to advance care in this area of unmet need.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac207","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T04:41:14Z","timestamp":1649220074000},"page":"190-199","source":"Crossref","is-referenced-by-count":23,"title":["Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3062-7328","authenticated-orcid":false,"given":"Sudha","family":"Raghunath","sequence":"first","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University"},{"name":"Rheumatology Department, Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K","family":"Guymer","sequence":"additional","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University"},{"name":"Rheumatology Department, Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-7768","authenticated-orcid":false,"given":"Yifat","family":"Glikmann-Johnston","sequence":"additional","affiliation":[{"name":"Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5691-4344","authenticated-orcid":false,"given":"Vera","family":"Golder","sequence":"additional","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University"},{"name":"Rheumatology Department, Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangi","family":"Kandane Rathnayake","sequence":"additional","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-3338","authenticated-orcid":false,"given":"Eric F","family":"Morand","sequence":"additional","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University"},{"name":"Rheumatology Department, Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9637-8590","authenticated-orcid":false,"given":"Julie C","family":"Stout","sequence":"additional","affiliation":[{"name":"Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9416-7383","authenticated-orcid":false,"given":"Alberta","family":"Hoi","sequence":"additional","affiliation":[{"name":"Centre for Inflammatory Disease, School of Clinical Sciences, Monash University"},{"name":"Rheumatology Department, Monash Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"2022122410030436000_keac207-B1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"2022122410030436000_keac207-B2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Al Rayes","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2022122410030436000_keac207-B3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/art.23090","article-title":"Impact of memory impairment on employment status in persons with systemic lupus erythematosus","volume":"57","author":"Panopalis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/art.24346","article-title":"Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study","volume":"61","author":"Appenzeller","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B5","author":"Arntsen"},{"key":"2022122410030436000_keac207-B6","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/S2665-9913(21)00331-3","article-title":"Cognitive dysfunction in systemic lupus erythematosus: how do we advance our understanding?","volume":"4","author":"Raghunath","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2022122410030436000_keac207-B7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0961203310382430","article-title":"Do subjective cognitive complaints correlate with cognitive impairment in systemic lupus erythematosus? A Danish outpatient study","volume":"20","author":"Vogel","year":"2011","journal-title":"Lupus"},{"key":"2022122410030436000_keac207-B8","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3899\/jrheum.111504","article-title":"Screening for cognitive impairment in systemic lupus erythematosus","volume":"39","author":"Hanly","year":"2012","journal-title":"J Rheumatol"},{"key":"2022122410030436000_keac207-B9","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3899\/jrheum.091366","article-title":"Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus","volume":"37","author":"Petri","year":"2010","journal-title":"J Rheumatol"},{"key":"2022122410030436000_keac207-B10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2022122410030436000_keac207-B11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/13803395.2017.1422699","article-title":"Meta-analysis of cognitive performance in fibromyalgia","volume":"40","author":"Bell","year":"2018","journal-title":"J Clin Exp Neuropsychol"},{"key":"2022122410030436000_keac207-B12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.semarthrit.2019.03.004","article-title":"Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus","volume":"49","author":"Kwan","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2022122410030436000_keac207-B13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3899\/jrheum.080212","article-title":"Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity","volume":"36","author":"Wolfe","year":"2009","journal-title":"J Rheumatol"},{"key":"2022122410030436000_keac207-B14","first-page":"S261","article-title":"A self-report cognitive symptoms inventory to assess patients with rheumatic diseases: Results in eosinophilia-myalgia syndrome (EMS), fibromyalgia, rheumatoid arthritis (RA), and other rheumatic diseases","volume-title":"Arthritis Rheum","author":"Pincus","year":"1996"},{"key":"2022122410030436000_keac207-B15","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/NDT.S199746","article-title":"Cognitive impairment in depression: recent advances and novel treatments","volume":"15","author":"Perini","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2022122410030436000_keac207-B16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fpsyg.2019.00004","article-title":"The relationship of anxiety and stress with working memory performance in a large non-depressed sample","volume":"10","author":"Lukasik","year":"2019","journal-title":"Front Psychol"},{"key":"2022122410030436000_keac207-B17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5694\/mja16.01282","article-title":"The Australian lupus registry and biobank: a timely initiative","volume":"206","author":"O'Neill","year":"2017","journal-title":"Med J Aust"},{"key":"2022122410030436000_keac207-B18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B19","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B20","doi-asserted-by":"crossref","first-page":"e000372","DOI":"10.1136\/lupus-2019-000372","article-title":"High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus","volume":"7","author":"Koelmeyer","year":"2020","journal-title":"Lupus Sci Med"},{"key":"2022122410030436000_keac207-B21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B22","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/art.1780391213","article-title":"Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease","volume":"39","author":"Kozora","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.20692","article-title":"Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus","volume":"51","author":"Kozora","year":"2004","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022122410030436000_keac207-B24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/0961203307079044","article-title":"Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials","volume":"16","author":"Mikdashi","year":"2007","journal-title":"Lupus"},{"key":"2022122410030436000_keac207-B25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.10457","article-title":"Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory","volume":"47","author":"Alarc\u00f3n","year":"2002","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022122410030436000_keac207-B26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"2022122410030436000_keac207-B27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"2022122410030436000_keac207-B28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/0961203313476360","article-title":"Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus","volume":"22","author":"Kosinski","year":"2013","journal-title":"Lupus"},{"key":"2022122410030436000_keac207-B29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36)","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2022122410030436000_keac207-B30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/ket171","article-title":"Predictors of self-reported health-related quality of life in systemic lupus erythematosus","volume":"52","author":"Kiani","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2022122410030436000_keac207-B31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.20409","article-title":"Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course","volume":"51","author":"Alarc\u00f3n","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00296-014-3208-7","article-title":"Fibrofog and fibromyalgia: a narrative review and implications for clinical practice","volume":"35","author":"Kravitz","year":"2015","journal-title":"Rheumatol Int"},{"key":"2022122410030436000_keac207-B33","first-page":"S6","article-title":"Fibro-fog","volume":"34","author":"Torta","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2022122410030436000_keac207-B34","first-page":"2367","article-title":"Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus","volume":"27","author":"Gladman","year":"2000","journal-title":"J Rheumatol"},{"key":"2022122410030436000_keac207-B35","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/acr.24349","article-title":"Cognitive function trajectories in association with the depressive symptoms trajectories in systemic lupus erythematosus over time","volume":"73","author":"Touma","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022122410030436000_keac207-B36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/0961203313511554","article-title":"Patient-reported fatigue and its impact on patients with systemic lupus erythematosus","volume":"23","author":"Sterling","year":"2014","journal-title":"Lupus"},{"key":"2022122410030436000_keac207-B37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.22101","article-title":"Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery","volume":"55","author":"Kozora","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2022122410030436000_keac207-B38","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ctrv.2012.05.002","article-title":"Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review","volume":"38","author":"Hutchinson","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"2022122410030436000_keac207-B39","first-page":"51","article-title":"Does the cognitive index of the symptom severity scale evaluate cognition? Data from subjective and objective cognitive measures in fibromyalgia","volume":"37","author":"Elkana","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2022122410030436000_keac207-B40","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1038\/s41598-017-04353-w","article-title":"Discrepancy between objective and subjective cognition in adults with major depressive disorder","volume":"7","author":"Srisurapanont","year":"2017","journal-title":"Sci Rep"},{"key":"2022122410030436000_keac207-B41","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"2012","edition":"5th edn"},{"key":"2022122410030436000_keac207-B42","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/1352458520958359","article-title":"Depression and cognitive function in early multiple sclerosis: multitasking is more sensitive than traditional assessments","volume":"27","author":"Glukhovsky","year":"2021","journal-title":"Multiple Sclerosis J"},{"key":"2022122410030436000_keac207-B43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1586\/erp.11.38","article-title":"Measuring outcomes in systemic lupus erythematosus clinical trials","volume":"11","author":"Strand","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2022122410030436000_keac207-B44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/03009742.2016.1206617","article-title":"Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus","volume":"46","author":"Flores","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"2022122410030436000_keac207-B45","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/1756-185X.13320","article-title":"Differences in quality of life determinants according to the presence of fibromyalgia in middle-aged female patients with systemic lupus erythematosus: a multicenter, cross-sectional, single-ethnicity cohort","volume":"21","author":"Moon","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2022122410030436000_keac207-B46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.berh.2013.07.009","article-title":"Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus","volume":"27","author":"Schmeding","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2022122410030436000_keac207-B47","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11064-019-02805-5","article-title":"Possible molecular mediators involved and mechanistic insight into fibromyalgia and associated co-morbidities","volume":"44","author":"Singh","year":"2019","journal-title":"Neurochem Res"},{"key":"2022122410030436000_keac207-B48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-015-8716-3","article-title":"Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus","volume":"63","author":"Mackay","year":"2015","journal-title":"Immunol Res"},{"key":"2022122410030436000_keac207-B49","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00296-017-3819-x","article-title":"Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus","volume":"37","author":"de Almeida Mac\u00eado","year":"2017","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac207\/43491320\/keac207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/190\/48409024\/keac207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/190\/48409024\/keac207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T10:05:06Z","timestamp":1671876306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/1\/190\/6564010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,5]]},"published-print":{"date-parts":[[2022,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac207","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,4,5]]}}}